2025-02-27 Exercise |
2025-03-03 7:02 pm |
2024-07-09 2026-07-09 |
BiomX Inc. |
PHGE |
Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director |
3,223,726 |
$0 |
4,575,556 (Indirect) |
View |
2025-02-27 Exercise |
2025-03-03 7:02 pm |
N/A N/A |
BiomX Inc. |
PHGE |
Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director |
353,249 |
$0.9306 |
4,575,556 (Indirect) |
View |
2025-02-27 Option Award |
2025-03-03 7:02 pm |
N/A N/A |
BiomX Inc. |
PHGE |
Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director |
2,517,228 |
$0 |
4,575,556 (Indirect) |
View |
2024-09-17 Conversion |
2024-09-17 6:16 pm |
N/A N/A |
Bicara Therapeutics Inc. |
BCAX |
Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner |
16,809,237 |
$0 |
897,587 (Indirect) |
View |
Ownership |
2024-09-12 9:07 pm |
N/A N/A |
Bicara Therapeutics Inc. |
BCAX |
Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner |
0 |
$0 |
1,725,174 (Indirect) |
View |
2024-07-15 Exercise |
2024-07-17 6:09 pm |
N/A N/A |
BiomX Inc. |
PHGE |
Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director |
5,894,766 |
$0 |
9,033,963 (Indirect) |
View |
2024-07-09 Option Award |
2024-07-11 6:47 pm |
N/A 2027-01-28 |
BiomX Inc. |
PHGE |
Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director 10% Owner |
41,794,350 |
$0 |
41,794,350 (Indirect) |
View |
2024-03-15 Option Award |
2024-03-19 9:39 pm |
N/A N/A |
BiomX Inc. |
PHGE |
Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director 10% Owner |
3,162,729 |
$0 |
3,189,709 (Indirect) |
View |
2022-05-10 Conversion |
2022-05-10 6:22 pm |
N/A N/A |
PepGen Inc. |
PEPG |
Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. Possible Member of 10% Group 10% Owner |
815,106 |
$0 |
476,813 (Indirect) |
View |
Ownership |
2022-05-05 8:00 pm |
N/A N/A |
PepGen Inc. |
PEPG |
Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner |
0 |
$0 |
536,960 (Indirect) |
View |
2021-10-26 Conversion |
2021-10-28 7:15 pm |
N/A N/A |
Xilio Therapeutics Inc. |
XLO |
Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Possible Member of 10% Group 10% Owner |
15,129,450 |
$0 |
1,143,972 (Indirect) |
View |
Ownership |
2021-10-21 9:36 pm |
N/A N/A |
Xilio Therapeutics Inc. |
XLO |
Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. *Possible Member of 10% Group 10% Owner |
0 |
$0 |
1,512,944 (Indirect) |
View |